Automated Insulin Delivery Systems Market 2026

December 2025 | 219 pages | ID: A8DD8472FE60EN
DataM Intelligence

Abstracts

The Automated Insulin Delivery Systems Market was valued at in and is anticipated to reach by , at a CAGR of 0.097 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Automated Insulin Delivery Systems Market.

This report delivers a comprehensive overview of the Automated Insulin Delivery Systems Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Automated Insulin Delivery Systems Market. The Automated Insulin Delivery Systems Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

Automated Insulin Delivery Systems Market Scope:

By Device Type

• Reusable Insulin Pens
• Disposable Insulin Pens

By Insulin Pumps

• External/ Tethered Pumps
• Implanted Insulin pump (IIP)
• Patch Pumps
• Closed loop insulin pump
• Others

By Pen Needles

• Standard Pen Needles
• Safety Pen Needles
• Others

By End user

• Hospitals
• Clinics
• Homecare
• Others

Key Players

• Medtronic
• Novo Nordisk
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• Ypsomed AG
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Biocon
• Bigfoot Biomedical, Inc.
• sanofi-aventis U.S. LLC(LIST NOT EXHAUSTIVE)

Major Highlights

This report delivers a comprehensive overview of the Automated Insulin Delivery Systems Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Automated Insulin Delivery Systems Market. The Automated Insulin Delivery Systems Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Device Type
3.2. Market Snippet by Insulin Pumps
3.3. Market Snippet by Pen Needles
3.4. Market Snippet by End User
3.5. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Advancement in next-generation automatic insulin delivery systems is expected to drive market growth.
  4.1.2. Restraints:
    4.1.2.1. The drawbacks associated with automated insulin delivery systems are expected to hamper market growth.
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Supply Chain Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Unmet Needs

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY DEVICE TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  7.1.2. Market Attractiveness Index, By Device Type Segment
7.2. Reusable Insulin Pens*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Disposable Insulin Pens

8. BY INSULIN PUMPS

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insulin Pumps
  8.1.2. Market Attractiveness Index, By Insulin Pumps Segment
8.2. External/ Tethered Pumps*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Implanted Insulin pump (IIP)
8.4. Patch Pumps
8.5. Closed loop insulin pump
8.6. Others

9. BY PEN NEEDLES

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pen Needles
  9.1.2. Market Attractiveness Index, By Pen Needles Segment
9.2. Standard Pen Needles*
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Safety Pen Needles
9.4. Others

10. BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  10.1.2. Market Attractiveness Index, By End user Segment
10.2. Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
10.3. Clinics
10.4. Homecare
10.5. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insulin Pump
  11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pen Needles
  11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insulin Pump
  11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pen Needles
  11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. U.K.
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insulin Pump
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pen Needles
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insulin Pump
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pen Needles
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insulin Pump
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Pen Needles
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch

13. COMPANY PROFILES

13.1. Medtronic*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Novo Nordisk
13.3. Insulet Corporation
13.4. Tandem Diabetes Care, Inc.
13.5. Ypsomed AG
13.6. F. Hoffmann-La Roche Ltd.
13.7. Becton, Dickinson and Company
13.8. Biocon
13.9. Bigfoot Biomedical, Inc.
13.10. sanofi-aventis U.S. LLC(*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us